<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en"><?DTDIdentifier.IdentifierValue http://www.biomedcentral.com/xml/article.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName article.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName bmc2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">BMC Microbiol</journal-id><journal-title-group><journal-title>BMC Microbiology</journal-title></journal-title-group><issn pub-type="epub">1471-2180</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3922988</article-id><article-id pub-id-type="publisher-id">1471-2180-14-31</article-id><article-id pub-id-type="pmid">24512075</article-id><article-id pub-id-type="doi">10.1186/1471-2180-14-31</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Hyperexpression of &#x003b1;-hemolysin explains enhanced virulence of sequence type 93 community-associated methicillin-resistant <italic>Staphylococcus aureus</italic></article-title></title-group><contrib-group><contrib contrib-type="author" id="A1"><name><surname>Chua</surname><given-names>Kyra YL</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I3">3</xref><xref ref-type="aff" rid="I4">4</xref><email>kychua@unimelb.edu.au</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Monk</surname><given-names>Ian R</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>ian.monk@unimelb.edu.au</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Lin</surname><given-names>Ya-Hsun</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>ya-hsun.lin@unimelb.edu.au</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Seemann</surname><given-names>Torsten</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>torsten.seemann@monash.edu</email></contrib><contrib contrib-type="author" id="A5"><name><surname>Tuck</surname><given-names>Kellie L</given-names></name><xref ref-type="aff" rid="I6">6</xref><email>kellie.tuck@monash.edu</email></contrib><contrib contrib-type="author" id="A6"><name><surname>Porter</surname><given-names>Jessica L</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>jlporter@unimelb.edu.au</email></contrib><contrib contrib-type="author" id="A7"><name><surname>Stepnell</surname><given-names>Justin</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>justin.stepnell@monash.edu</email></contrib><contrib contrib-type="author" id="A8"><name><surname>Coombs</surname><given-names>Geoffrey W</given-names></name><xref ref-type="aff" rid="I7">7</xref><xref ref-type="aff" rid="I8">8</xref><email>Geoffrey.Coombs@health.wa.gov.au</email></contrib><contrib contrib-type="author" id="A9"><name><surname>Davies</surname><given-names>John K</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>john.davies@monash.edu</email></contrib><contrib contrib-type="author" id="A10"><name><surname>Stinear</surname><given-names>Timothy P</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>tstinear@unimelb.edu.au</email></contrib><contrib contrib-type="author" corresp="yes" id="A11"><name><surname>Howden</surname><given-names>Benjamin P</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I3">3</xref><xref ref-type="aff" rid="I4">4</xref><email>benjamin.howden@austin.org.au</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Microbiology and Immunology, University of Melbourne, Melbourne, Victoria 3052, Australia</aff><aff id="I2"><label>2</label>Department of Microbiology, Monash University, Clayton, Victoria 3800, Australia</aff><aff id="I3"><label>3</label>Austin Centre for Infection Research (ACIR), Infectious Diseases Department, Austin Health, PO Box 5555, Heidelberg, Victoria 3084, Australia</aff><aff id="I4"><label>4</label>Microbiology Department, Austin Health, Heidelberg, Victoria 3084, Australia</aff><aff id="I5"><label>5</label>Victorian Bioinformatics Consortium, Monash University, Clayton, Victoria 3800, Australia</aff><aff id="I6"><label>6</label>School of Chemistry, Monash University, Clayton, Victoria 3800, Australia</aff><aff id="I7"><label>7</label>Australian Collaborating Centre for Enterococcus and Staphylococcus Species (ACCESS) Typing and Research, PathWest Laboratory Medicine-WA, Royal Perth Hospital, Perth, Western Australia 6000, Australia</aff><aff id="I8"><label>8</label>School of Biomedical Sciences, Curtin University, Bentley, Western Australia 6102, Australia</aff><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>10</day><month>2</month><year>2014</year></pub-date><volume>14</volume><fpage>31</fpage><lpage>31</lpage><history><date date-type="received"><day>6</day><month>12</month><year>2013</year></date><date date-type="accepted"><day>5</day><month>2</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 Chua et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Chua et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (
<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://www.biomedcentral.com/1471-2180/14/31"/><abstract><sec><title>Background</title><p>The community-associated methicillin-resistant <italic>S. aureus</italic> (CA-MRSA) ST93 clone is becoming dominant in Australia and is clinically highly virulent. In addition, sepsis and skin infection models demonstrate that ST93 CA-MRSA is the most virulent global clone of <italic>S. aureus</italic> tested to date. While the determinants of virulence have been studied in other clones of CA-MRSA, the basis for hypervirulence in ST93 CA-MRSA has not been defined.</p></sec><sec><title>Results</title><p>Here, using a geographically and temporally dispersed collection of ST93 isolates we demonstrate that the ST93 population hyperexpresses key CA-MRSA exotoxins, in particular &#x003b1;-hemolysin, in comparison to other global clones. Gene deletion and complementation studies, and virulence comparisons in a murine skin infection model, showed unequivocally that increased expression of &#x003b1;-hemolysin is the key staphylococcal virulence determinant for this clone. Genome sequencing and comparative genomics of strains with divergent exotoxin profiles demonstrated that, like other <italic>S. aureus</italic> clones, the quorum sensing <italic>agr</italic> system is the master regulator of toxin expression and virulence in ST93 CA-MRSA. However, we also identified a previously uncharacterized AraC/XylS family regulator (AryK) that potentiates toxin expression and virulence in <italic>S. aureus</italic>.</p></sec><sec><title>Conclusions</title><p>These data demonstrate that hyperexpression of &#x003b1;-hemolysin mediates enhanced virulence in ST93 CA-MRSA, and additional control of exotoxin production, in particular &#x003b1;-hemolysin, mediated by regulatory systems other than <italic>agr</italic> have the potential to fine-tune virulence in CA-MRSA.</p></sec></abstract><kwd-group><kwd><italic>Staphylococcus aureus</italic></kwd><kwd>CA-MRSA</kwd><kwd>Pathogenesis</kwd><kwd>Alpha-hemolysin</kwd></kwd-group></article-meta></front><body><sec><title>Background</title><p>Community-associated methicillin-resistant <italic>Staphylococcus aureus</italic> (CA-MRSA) is an emerging global problem with very similar clinical presentations across different clones<italic>,</italic> despite significant genetic diversity
[<xref ref-type="bibr" rid="B1">1</xref>]. Many CA-MRSA strains carry <italic>lukSF-PV</italic> in the accessory genome, which encodes the Panton-Valentine leukocidin (PVL), an exotoxin that causes neutrophil lysis
[<xref ref-type="bibr" rid="B1">1</xref>]. Although there has been considerable controversy as to the role of this toxin in CA-MRSA pathogenesis, some of this may be explained by a variable, species dependent susceptibility to PVL &#x02013; human and rabbit neutrophils are lysed by PVL at very low concentrations whilst mouse and monkey neutrophils are less susceptible, making the interpretation of animal model data difficult in some cases
[<xref ref-type="bibr" rid="B2">2</xref>]. Additionally, the importance of PVL is also likely to be dependent on the site of infection. In the rabbit pneumonia model, PVL has been demonstrated to have a clear role in mediating severe lung necrosis and inflammation
[<xref ref-type="bibr" rid="B3">3</xref>]. In contrast, in skin infection, even in the rabbit model, its role remains less clear
[<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>].</p><p>Notwithstanding PVL, the increased expression of other core genome virulence determinants also contributes significantly to the increased virulence of CA-MRSA strains
[<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>]. These include &#x003b1;-hemolysin (Hla) and &#x003b1;-type phenol soluble modulins (PSMs). Hla is a pore-forming exotoxin that lyses many cells including red cells, platelets, monocytes and endothelial cells
[<xref ref-type="bibr" rid="B8">8</xref>]. Hla has been demonstrated to be an important mediator of virulence in skin infection and pneumonia
[<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>]. The &#x003b1;-type PSMs have been recently characterized and they lyse neutrophils and red cells
[<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>]. The &#x003b1;-type PSMs also mediate virulence in skin infection and septicemia and of these, PSM&#x003b1;3 is the most potent
[<xref ref-type="bibr" rid="B11">11</xref>].</p><p>The study of unique, distantly related CA-MRSA clones that also demonstrate enhanced virulence, may provide insights into the emergence of the global CA-MRSA phenomenon, and also help define the genomic determinants of enhanced virulence. In Australia, the singleton ST93 CA-MRSA clone ST93 ("Queensland clone") has become dominant in the community
[<xref ref-type="bibr" rid="B13">13</xref>], and we and others have demonstrated that our reference ST93 strain JKD6159 was highly virulent and caused severe skin infection in a mouse model compared to other CA-MRSA strains including USA300
[<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>].</p><p>In this study we used exotoxin analysis, functional genomics and a murine infection model to investigate the relative contribution of &#x003b1;-hemolysin, &#x003b1;-type phenol soluble modulins and Panton-Valentine leukocidin to the enhanced virulence of ST93 CA-MRSA. We show that increased virulence in the BALB/c mouse skin infection model is less dependent on &#x003b1;-type phenol soluble modulin or Panton-Valentine leukocidin production but is instead due to high-level expression of &#x003b1;-hemolysin in this clone, controlled predominantly by the <italic>agr</italic> system.</p></sec><sec><title>Results and discussion</title><p>The emergence of CA-MRSA is a major public health issue, and there is a clear need to understand the basis for both virulence and transmission of global clones of CA-MRSA. The genetically distinct CA-MRSA clone ST93-IV [2B] has rapidly become the dominant clone in Australia and its rise accounts for the increase in incidence of CA-MRSA as a whole in this country
[<xref ref-type="bibr" rid="B13">13</xref>]. We, and others have previously shown that ST93 strain JKD6159 is the most virulent global clone of <italic>S. aureus</italic> in murine models
[<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. To determine the mediators of virulence in this clone we initially studied exotoxin expression in a large collection of ST93 <italic>S. aureus</italic> from around Australia, and compared representative high and low expressing strains to an international selection of clones.</p><sec><title>Exotoxin expression in ST93 CA-MRSA strains</title><p><italic>Staphylococcus aureus</italic> expresses a wide range of exotoxins that may contribute to virulence. Because Hla, PVL and &#x003b1;-type PSMs have been found by others to be important virulence factors in CA-MRSA strains
[<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B16">16</xref>], we measured <italic>in vitro</italic> expression of these exotoxins by the wildtype ST93 strains and non-ST93 comparator strains. The main isolates used in this study are described in Table&#x000a0;
<xref ref-type="table" rid="T1">1</xref>, while the collection of ST93 isolates from around Australia used for comparative exotoxin expression is from a study by Coombs <italic>et al.</italic>[<xref ref-type="bibr" rid="B17">17</xref>] and summarized in Additional file
<xref ref-type="supplementary-material" rid="S1">1</xref>. The comparison of expression of international clones to the ST93 reference strain JKD6159 and three additional ST93 strains selected for genome sequencing (see below) are shown in Figure&#x000a0;
<xref ref-type="fig" rid="F1">1</xref>, while the results for all 59 ST93 isolates compared to USA300 are shown in Additional file
<xref ref-type="supplementary-material" rid="S2">2</xref> (&#x003b1;-type PSMs) and Additional file
<xref ref-type="supplementary-material" rid="S3">3</xref> (Hla). The results of PVL analysis for the ST93 collection has been previously reported
[<xref ref-type="bibr" rid="B17">17</xref>]. Because PVL is a 2-component exotoxin and both LukS-PV and LukF-PV are required for activity, we chose to measure LukF-PV expression by quantitative Western blot. LukF-PV was chosen over LukS-PV to obtain anti-LukF-PV antibody with increased specificity of binding as there was more sequence divergence between <italic>lukF-PV</italic> and the orthologous 2-component <italic>S. aureus</italic> exotoxins compared to <italic>lukS-PV</italic>. Although there are four &#x003b1;-type PSMs, PSM&#x003b1;3 causes the most significant neutrophil lysis
[<xref ref-type="bibr" rid="B11">11</xref>] and we measured deformylated and N-formylated PSM&#x003b1;3 expression by high performance liquid chromatography (HPLC). The proportion of deformylated and formylated forms of PSMs depends on the growth conditions, the activity of staphylococcal peptide deformylase and strain background
[<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B18">18</xref>].</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Bacterial strains used in this study</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th align="left"><bold>
<italic>S. aureus </italic>
</bold><bold>strain</bold></th><th align="left"><bold>Molecular type</bold></th><th align="left"><bold>Date of isolation</bold></th><th align="left"><bold>Place of isolation</bold></th><th align="left"><bold>Site of isolation</bold></th><th align="left"><bold>Relevant characteristics</bold></th><th align="left"><bold>
<italic>lukSF-PV</italic>
</bold></th><th align="left"><bold>reference</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom"><bold>
<italic>Clinical isolates</italic>
</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">JKD6159<hr/></td><td align="left" valign="bottom">ST93-IV [2B]<hr/></td><td align="left" valign="bottom">2004<hr/></td><td align="left" valign="bottom">Victoria, Australia<hr/></td><td align="left" valign="bottom">Blood<hr/></td><td align="left" valign="bottom">Dominant Australian CA-MRSA clone<hr/></td><td align="left" valign="bottom">+<hr/></td><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B14">14</xref>]<hr/></td></tr><tr><td align="left" valign="bottom">TPS3104<hr/></td><td align="left" valign="bottom">ST93-IV [2B]<hr/></td><td align="left" valign="bottom">2009<hr/></td><td align="left" valign="bottom">Western Australia, Australia<hr/></td><td align="left" valign="bottom">Nasal cavity<hr/></td><td align="left" valign="bottom">Dominant Australian CA-MRSA clone<hr/></td><td align="left" valign="bottom">+<hr/></td><td align="left" valign="bottom">This study<hr/></td></tr><tr><td align="left" valign="bottom">TPS3105<hr/></td><td align="left" valign="bottom">ST93-IV [2B]<hr/></td><td align="left" valign="bottom">2005<hr/></td><td align="left" valign="bottom">New South Wales, Australia<hr/></td><td align="left" valign="bottom">Blood<hr/></td><td align="left" valign="bottom">Australian CA-MRSA clone<hr/></td><td align="left" valign="bottom">-<hr/></td><td align="left" valign="bottom">This study<hr/></td></tr><tr><td align="left" valign="bottom">TPS3106<hr/></td><td align="left" valign="bottom">ST93-V [5C2&#x00026;5]<hr/></td><td align="left" valign="bottom">2008<hr/></td><td align="left" valign="bottom">Western Australia, Australia<hr/></td><td align="left" valign="bottom">Nasal cavity<hr/></td><td align="left" valign="bottom">Australian CA-MRSA clone<hr/></td><td align="left" valign="bottom">-<hr/></td><td align="left" valign="bottom">This study<hr/></td></tr><tr><td align="left" valign="bottom">JKD6272<hr/></td><td align="left" valign="bottom">ST1-IV [2B]<hr/></td><td align="left" valign="bottom">2002<hr/></td><td align="left" valign="bottom">Victoria, Australia<hr/></td><td align="left" valign="bottom">Blood<hr/></td><td align="left" valign="bottom">Australian CA-MRSA clone<hr/></td><td align="left" valign="bottom">-<hr/></td><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B14">14</xref>]<hr/></td></tr><tr><td align="left" valign="bottom">JKD6260<hr/></td><td align="left" valign="bottom">ST1-IV [2B]<hr/></td><td align="left" valign="bottom">2008<hr/></td><td align="left" valign="bottom">Western Australia, Australia<hr/></td><td align="left" valign="bottom">Skin<hr/></td><td align="left" valign="bottom">Australian CA-MRSA clone<hr/></td><td align="left" valign="bottom">+<hr/></td><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B14">14</xref>]<hr/></td></tr><tr><td align="left" valign="bottom">JKD6177<hr/></td><td align="left" valign="bottom">ST30-IV [2B]<hr/></td><td align="left" valign="bottom">2003<hr/></td><td align="left" valign="bottom">Melbourne, Australia<hr/></td><td align="left" valign="bottom">Blood<hr/></td><td align="left" valign="bottom">Australian CA-MRSA clone<hr/></td><td align="left" valign="bottom">+<hr/></td><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B14">14</xref>]<hr/></td></tr><tr><td align="left" valign="bottom">FPR3757 USA300<hr/></td><td align="left" valign="bottom">ST8-IV [2B]<hr/></td><td align="left" valign="bottom">NA<hr/></td><td align="left" valign="bottom">San Francisco, USA<hr/></td><td align="left" valign="bottom">Wrist abscess<hr/></td><td align="left" valign="bottom">Dominant North American CA-MRSA clone<hr/></td><td align="left" valign="bottom">+<hr/></td><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B19">19</xref>]<hr/></td></tr><tr><td align="left" valign="bottom">JKD6009<hr/></td><td align="left" valign="bottom">ST239-III [3A]<hr/></td><td align="left" valign="bottom">2002<hr/></td><td align="left" valign="bottom">New Zealand<hr/></td><td align="left" valign="bottom">Wound<hr/></td><td align="left" valign="bottom">Dominant Australian hospital-associated MRSA clone, AUS2/3<hr/></td><td align="left" valign="bottom">-<hr/></td><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B20">20</xref>]<hr/></td></tr><tr><td align="left" valign="bottom"><bold>
<italic>Mutant strains</italic>
</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">JKD6159&#x02206;<italic>lukSF-PV</italic><hr/></td><td align="left" valign="bottom">ST93-IV [2B]<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">Isogenic unmarked <italic>lukSF-PV</italic> KO of JKD6159<hr/></td><td align="left" valign="bottom">-<hr/></td><td align="left" valign="bottom">This study<hr/></td></tr><tr><td align="left" valign="bottom">JKD6159&#x02206;<italic>hla</italic><hr/></td><td align="left" valign="bottom">ST93-IV [2B]<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">Isogenic unmarked <italic>hla</italic> KO of JKD6159. Deletion encompassed genome coordinates 1121291&#x02013;1120441.<hr/></td><td align="left" valign="bottom">+<hr/></td><td align="left" valign="bottom">This study<hr/></td></tr><tr><td align="left" valign="bottom">JKD6159&#x02206;<italic>hla r</italic><hr/></td><td align="left" valign="bottom">ST93-IV [2B]<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">Isogenic unmarked <italic>hla</italic> KO repaired in JKD6159&#x02206;<italic>hla</italic>. Introduction of a novel PstI site within <italic>hla</italic>.<hr/></td><td align="left" valign="bottom">+<hr/></td><td align="left" valign="bottom">This study<hr/></td></tr><tr><td align="left" valign="bottom">JKD6159&#x02206;<italic>psm&#x003b1;</italic><hr/></td><td align="left" valign="bottom">ST93-IV [2B]<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">Isogenic unmarked <italic>psm-&#x003b1;</italic> KO in JKD6159. Deletion encompassed genome coordinates 453364&#x02013;45378.<hr/></td><td align="left" valign="bottom">+<hr/></td><td align="left" valign="bottom">This study<hr/></td></tr><tr><td align="left" valign="bottom">JKD6159&#x02206;<italic>psm&#x003b1; r</italic><hr/></td><td align="left" valign="bottom">ST93-IV [2B]<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">Isogenic unmarked <italic>psm-&#x003b1;</italic> KO repaired in JKD6159&#x02206;<italic>psm-&#x003b1;</italic>. Introduction of a novel SalI site within <italic>psm-&#x003b1;</italic><hr/></td><td align="left" valign="bottom">+<hr/></td><td align="left" valign="bottom">This study<hr/></td></tr><tr><td align="left" valign="bottom">JKD6159&#x02206;00043<hr/></td><td align="left" valign="bottom">ST93-IV [2B]<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">Isogenic unmarked SAA6159_00043 KO of JKD6159. Deletion encompassed genome coordinates 53156 - 54561<hr/></td><td align="left" valign="bottom">+<hr/></td><td align="left" valign="bottom">This study<hr/></td></tr><tr><td align="left" valign="bottom">JKD6159_AraC<italic>r</italic><hr/></td><td align="left" valign="bottom">ST93-IV [2B]<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">Isogenic AraC/XylS regulator repaired in JKD6159<hr/></td><td align="left" valign="bottom">+<hr/></td><td align="left" valign="bottom">This study<hr/></td></tr><tr><td align="left">TPS3105<italic>r</italic></td><td align="left">ST93-IV [2B]</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td><td align="left">&#x000a0;</td><td align="left">Isogenic <italic>agrA</italic> repair of TPS3105</td><td align="left">-</td><td align="left">This study</td></tr></tbody></table><table-wrap-foot><p>KO: knockout, NA: not available.</p></table-wrap-foot></table-wrap><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold><italic>In vitro </italic></bold><bold>exotoxin expression of wildtype </bold><bold><italic>S. aureus </italic></bold><bold>isolates.</bold> JKD6159 (ST93-IV [2B]) compared with non-ST93 CA-MRSA strains FPR 3757 USA300 (ST8-IV [2B]), JKD6177 (ST30-IV [2B]), and JKD6272 (ST1-IV [2B]); Hospital-associated MRSA strain JKD6009 (ST239-III [3A]), wildtype ST93 strains TPS3104 (ST93-IV [2B]), TPS3105 (ST93-IV [2B]), and TPS3106 (ST93-V [5C2&#x00026;5]). <bold>(A)</bold> LukF-PV expression measured by quantitative Western blot. RN4220 was included as a negative control because it does not contain <italic>lukF-PV</italic>. All PVL negative strains did not express LukF-PV<italic>.</italic> There was no significant difference in the amount of LukF-PV expressed by the <italic>S. aureus</italic> strains containing <italic>lukSF-PV</italic>. Data shown are mean intensity of bands in arbitrary units and SEM. <bold>(B)</bold> PSM&#x003b1;3 expression measured by HPLC. JKD6177 did not produce PSM&#x003b1;3. JKD6272 (p&#x02009;=&#x02009;0.0003), JKD6009 (p&#x02009;=&#x02009;0.0003), TPS3105 (p&#x02009;&#x0003c;&#x02009;0.0001) and TPS3106 (p&#x02009;=&#x02009;0.0100) produced less deformylated and N-formylated PSM&#x003b1;3 compared to JKD6159. There was no difference between PSM&#x003b1;3 production by JKD6159 and USA300. TPS3104 expressed more PSM&#x003b1;3 than JKD6159 (p&#x02009;=&#x02009;0.0029). Data shown are mean concentration (&#x003bc;g/ml), presented as vertical stacked bars and SEM. Deformylated PSM&#x003b1;3 is shown in grey bars. N-formylated PSM&#x003b1;3 is shown in white bars. <bold>(C)</bold> Hla expression measured by quantitative Western blot. RN4220 was included as a negative control because it does not express Hla. JKD6159 expressed more Hla compared to all non-ST93 wildtype strains (p&#x02009;&#x0003c;&#x02009;0.0001 for all strains except JKD6177 p&#x02009;=&#x02009;0.0107). TPS3105 and TPS3106 produced significantly less Hla (p&#x02009;&#x0003c;&#x02009;0.0001). There was no difference in Hla production between JKD6159 and TPS3104. Data shown are mean intensity of bands in arbitrary units and SEM. Note, ***p&#x02009;&#x0003c;&#x02009;0.001, **p&#x02009;&#x0003c;&#x02009;0.01, *p&#x02009;&#x0003c;&#x02009;0.05.</p></caption><graphic xlink:href="1471-2180-14-31-1"/></fig></sec><sec><title>PVL</title><p>As previously reported
[<xref ref-type="bibr" rid="B17">17</xref>], PVL expression was consistent across most ST93 strains. We found that there was no significant difference in the LukF-PV expression in the PVL positive strains JKD6159, TPS3104, USA300 and JKD6177. Although USA300 appeared to produce less LukF-PV than JKD6159, the difference was not statistically significant (p&#x02009;=&#x02009;0.0943, Figure&#x000a0;
<xref ref-type="fig" rid="F1">1</xref>A).</p></sec><sec><title>PSM&#x003b1;3</title><p>We found that the deformylated form of PSM&#x003b1;3 was almost always more abundant than the N-formylated form (Figure&#x000a0;
<xref ref-type="fig" rid="F1">1</xref>B and Additional file
<xref ref-type="supplementary-material" rid="S2">2</xref>). The ST30 CA-MRSA strain JKD6177 did not produce any PSM&#x003b1;3. There was no significant difference in PSM&#x003b1;3 expression between JKD6159 compared to USA300, however JKD6159 produced more PSM&#x003b1;3 compared to JKD6272 (p&#x02009;=&#x02009;0.0003) and JKD6009 (p&#x02009;=&#x02009;0.0003). Compared to the other ST93 MRSA strains, JKD6159 produced more PSM&#x003b1;3 compared to TPS3105 (p&#x02009;&#x0003c;&#x02009;0.0001), and TPS3106 (p&#x02009;=&#x02009;0.01) but less than TPS3104 (p&#x02009;=&#x02009;0.0029) (Figure&#x000a0;
<xref ref-type="fig" rid="F1">1</xref>B). Expression levels across the whole ST93 collection were variable, although many isolates produced levels at least equivalent to USA300 (Additional file
<xref ref-type="supplementary-material" rid="S2">2</xref>).</p></sec><sec><title>Hla</title><p>Hla expression appeared high for the majority of ST93 isolates, with the exception of four strains where expression was low (Additional file
<xref ref-type="supplementary-material" rid="S3">3</xref>). JKD6159 produced greater levels of Hla than all the wildtype strains, including USA300 (p&#x02009;&#x0003c;&#x02009;0.0001 for all strains except JKD6177, p&#x02009;=&#x02009;0.0107, Figure&#x000a0;
<xref ref-type="fig" rid="F1">1</xref>C). There was no difference in Hla expression between JKD6159 and TPS3104.</p><p>Here we have demonstrated that the majority of ST93 strains consistently produce higher levels of Hla compared to other clones, including USA300, while production of PVL and &#x003b1;-type PSM is similar, suggesting that enhanced expression of Hla may be responsible for increased virulence of ST93 CA-MRSA.</p></sec><sec><title>Comparative virulence of ST93 isolates with differential exotoxin expression</title><p>To further examine the role of these selected exotoxins in our mouse skin infection assay, we compared the virulence of four ST93 isolates selected based on their exotoxin expression profiles (high exotoxin expression, JKD6159 and TPS3104; low exotoxin expression, TPS3105 and TPS3106). TPS3104 was as virulent as JKD6159 in the mouse model in all outcome measures (Figure&#x000a0;
<xref ref-type="fig" rid="F2">2</xref>). In contrast, the strains with reduced exotoxin expression TPS3105 and TPS3106 were significantly less virulent compared to JKD6159, with less weight loss at day 5 of infection (p&#x02009;&#x0003c;&#x02009;0.0001), smaller lesion size (p&#x02009;&#x0003c;&#x02009;0.0001) and less CFU recovery from lesions (TPS3105, p&#x02009;=&#x02009;0.0177; TPS3106, p&#x02009;=&#x02009;0.0328) in the model (Figure&#x000a0;
<xref ref-type="fig" rid="F2">2</xref>).</p><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>Virulence characteristics of wildtype ST93 CA-MRSA isolates.</bold>&#x000a0;<italic>S. aureus</italic> JKD6159 compared with three other wildtype ST93 CA-MRSA isolates, TPS3104, TPS3105 and TPS3106 in a BALB/c mouse skin infection assay. At least 10 mice were used for each bacterial strain. <bold>(A)</bold> Weight loss induced by intradermal infection with <italic>S. aureus</italic> strains is demonstrated as percentage loss of weight over 5&#x000a0;days. The difference in percentage weight loss between JKD6159 and TPS3105 and TPS3106 was significant (p&#x02009;&#x0003c;&#x02009;0.0001). There was no difference in weight loss between JKD6159 and TPS3104. Data shown are mean weight loss and SEM. <bold>(B)</bold> Skin lesion area (mm<sup>2</sup>) at 5&#x000a0;days after infection was significantly greater with JKD6159 infected mice compared to TPS3105 and TPS3106 (p&#x02009;&#x0003c;&#x02009;0.0001). There was no difference in lesion area between JKD6159 and TPS3104. Data shown are mean area and SEM. <bold>(C)</bold> Recovery of <italic>S. aureus</italic> (log CFU) from infected tissues at 5&#x000a0;days after infection from JKD6159 infected mice was greater than with TPS3105 (p&#x02009;=&#x02009;0.0177) and TPS3106 infected mice (p&#x02009;=&#x02009;0.0328). There was no difference between JD6159 and TPS3104 infected mice. Data shown are mean CFU and SEM. Note, ***p&#x02009;&#x0003c;&#x02009;0.001, *p&#x02009;&#x0003c;&#x02009;0.05.</p></caption><graphic xlink:href="1471-2180-14-31-2"/></fig></sec><sec><title>Impact of exotoxin expression on virulence of ST93 CA-MRSA in the murine skin infection model</title><p>To further characterize the contribution of each of the exotoxins to disease in the murine model, genetic deletion and complementation experiments were performed for each of the selected toxins.</p></sec><sec><title>Hla</title><p>Given the increased <italic>in vitro</italic> expression of Hla by JKD6159 and TPS3104 and the apparent correlation of this increased expression with increased virulence in the mouse skin infection model, we generated JKD6159&#x02206;<italic>hla</italic> and assessed this mutant in the mouse skin infection assay (Figure&#x000a0;
<xref ref-type="fig" rid="F3">3</xref>). There was a marked attenuation in virulence in all outcome measures with significantly decreased weight loss (p&#x02009;&#x0003c;&#x02009;0.0001), lesion size (p&#x02009;&#x0003c;&#x02009;0.0001) and CFU recovery (p&#x02009;=&#x02009;0.0177). To confirm that an unintentional mutation introduced during the procedure to knock-out <italic>hla</italic> was not responsible for the reduced virulence in this strain, complete genome sequencing of the strain using Ion Torrent sequencing was performed. Mapping of sequence reads from JKD6159&#x02206;<italic>hla</italic> against JKD6159 (40&#x000d7; genome coverage) demonstrated no additional differences between JKD6159 and JKD6159&#x02206;<italic>hla.</italic> We also restored Hla function in this strain by using allelic replacement to repair the deletion in <italic>hla</italic> and create strain JKD6159&#x02206;<italic>hla r</italic>. As expected, Hla expression was absent in JKD6159&#x02206;<italic>hla</italic> and expression was restored in JKD6159&#x02206;<italic>hla r</italic> when tested by Western Blot (Additional file
<xref ref-type="supplementary-material" rid="S4">4</xref>A)<italic>.</italic> JKD6159&#x02206;<italic>hla r</italic> also reverted to high virulence in the mouse skin infection assay (Figure&#x000a0;
<xref ref-type="fig" rid="F3">3</xref>). The apparent slight reduction in virulence of this <italic>hla</italic> repaired strain compared to wild type JKD6159 is explained by incomplete penetration of the restored <italic>hla</italic> allele in JKD6159&#x02206;<italic>hla r</italic>, resulting in mixed bacterial populations and reversion to JKD6159&#x02206;<italic>hla</italic> for some of the mice (Additional file
<xref ref-type="supplementary-material" rid="S4">4</xref>B and C).</p><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>Virulence characteristics of </bold><bold><italic>S. aureus </italic></bold><bold>JKD6159 and isogenic exotoxin mutants derived from JKD6159.</bold> JKD6159 compared to isogenic PVL knockout (JKD6159&#x02206;<italic>lukSF-PV</italic>), isogenic Hla knockout (JKD6159&#x02206;<italic>hla</italic>), isogenic Hla complemented strain (JKD6159&#x02206;<italic>hla r</italic>) and isogenic PSM-&#x003b1; knockout (JKD6159&#x02206;<italic>psm&#x003b1;</italic>) in a BALB/c mouse skin infection assay. <bold>(A)</bold> Weight loss induced by intradermal infection with <italic>S. aureus</italic> strains is demonstrated as percentage loss of weight over 5&#x000a0;days. There was no significant difference between JKD6159, JKD6159&#x02206;<italic>lukSF-PV</italic> and JKD6159&#x02206;<italic>psm&#x003b1;</italic> infected mice. There was significantly less weight loss in mice infected with JKD6159&#x02206;<italic>hla</italic> compared to JKD6159 (p&#x02009;&#x0003c;&#x02009;0.0001). There was also less weight loss in mice infected with JKD6159&#x02206;<italic>hla</italic> compared to JKD6159&#x02206;<italic>hla r</italic> (p&#x02009;=&#x02009;0.0063). Mice infected with JKD6159&#x02206;<italic>hla r</italic> had less weight loss compared to JKD6159 (p&#x02009;=&#x02009;0.0004). Data shown are mean weight loss and SEM. <bold>(B)</bold> There was no difference in skin lesion area (mm<sup>2</sup>) at 5&#x000a0;days after infection in mice infected with JKD6159 and JKD6159&#x02206;<italic>lukSF-PV</italic> and JKD6159&#x02206;<italic>psm&#x003b1;.</italic> Mice infected with JKD6159&#x02206;<italic>hla</italic> had significantly smaller lesions (p&#x02009;&#x0003c;&#x02009;0.0001). In some mice, there was no cutaneous lesion seen. There were significantly smaller lesions in mice infected with JKD6159&#x02206;<italic>hla</italic> compared to JKD6159&#x02206;<italic>hla r</italic> (p&#x02009;&#x0003c;&#x02009;0.0001). Mice infected with JKD6159&#x02206;<italic>hla r</italic> had smaller lesions compared to JKD6159 (p&#x02009;=&#x02009;0.024). Data shown are mean area and SEM. <bold>(C)</bold> Recovery of <italic>S. aureus</italic> (log CFU) from infected tissues at 5&#x000a0;days after infection from JKD6159 infected mice was no different to that from JKD6159&#x02206;<italic>lukSF-PV</italic>, JKD6159&#x02206;<italic>psm&#x003b1;</italic> and JKD6159&#x02206;<italic>hla r.</italic> There was significantly less <italic>S. aureus</italic> recovered from JKD6159&#x02206;<italic>hla</italic> infected mice (p&#x02009;=&#x02009;0.0177). There was also significantly less <italic>S. aureus</italic> recovered from JKD6159&#x02206;<italic>hla</italic> infected mice compared to JKD6159&#x02206;<italic>hla r</italic> (p&#x02009;=&#x02009;0.0018). Data shown are mean CFU and SEM. Note, ***p&#x02009;&#x0003c;&#x02009;0.001, *p&#x02009;&#x0003c;&#x02009;0.05, compared to JKD6159.</p></caption><graphic xlink:href="1471-2180-14-31-3"/></fig></sec><sec><title>&#x003b1;-type PSMs</title><p>In order to determine the contribution of &#x003b1;-type PSMs to virulence of JKD6159, we generated JKD6159&#x02206;<italic>psm&#x003b1;</italic> (deletion of the whole &#x003b1;-type PSM locus) and assessed this mutant in the mouse skin infection assay (Figure&#x000a0;
<xref ref-type="fig" rid="F3">3</xref>). There was no significant difference in virulence in all outcome measures; weight loss (p&#x02009;=&#x02009;0.06), lesion size (p&#x02009;=&#x02009;0.8174) and CFU recovery (p&#x02009;=&#x02009;0.1925). The absence of PSM&#x003b1;3 production was verified by HPLC and the integrity of the JKD6159&#x02206;<italic>psm&#x003b1;</italic> was confirmed by complementation (Additional file
<xref ref-type="supplementary-material" rid="S5">5</xref>). It is noteworthy that the level of expression of PSM&#x003b1;3 by JKD6159 was similar to USA300 (Figure&#x000a0;
<xref ref-type="fig" rid="F1">1</xref>), a strain that produces high levels of PSMs and where a contribution to virulence has been demonstrated
[<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B11">11</xref>]. Despite this, the deletion mutant (JKD6159&#x02206;<italic>psm&#x003b1;</italic>) demonstrated no attenuation of virulence compared to JKD6159 (Figure&#x000a0;
<xref ref-type="fig" rid="F3">3</xref>). The significantly divergent genetic background of ST93 compared with USA300 may account for this difference in the importance of &#x003b1;-type PSMs to the virulence of JKD6159
[<xref ref-type="bibr" rid="B6">6</xref>].</p></sec><sec><title>PVL</title><p>We constructed an isogenic PVL negative mutant in JKD6159 by deleting <italic>lukSF-PV</italic>. Western Blot analysis confirmed the absence of LukF-PV in the mutant (Additional file
<xref ref-type="supplementary-material" rid="S6">6</xref>). Assessment of the JKD6159&#x00394;<italic>lukSF-PV</italic> mutant in the mouse skin infection model showed no decrease in virulence (Figure&#x000a0;
<xref ref-type="fig" rid="F3">3</xref>). Therefore PVL was not contributing to the increased virulence in JKD6159 in this murine model. Murine neutrophils, unlike rabbit and human neutrophils are relatively resistant to the effects of PVL so it is difficult to draw firm conclusions as to the human importance of this result
[<xref ref-type="bibr" rid="B2">2</xref>]. However, the aim of this study was to uncover the mechanisms for the observed increased virulence of ST93 previously demonstrated using this mouse model
[<xref ref-type="bibr" rid="B14">14</xref>]. Our results reinforce the results of others who have examined different <italic>S. aureus</italic> clones which indicate that Hla, rather than PVL is the main mediator of virulence in CA-MRSA in a mouse skin infection model
[<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>]. It should be noted that other authors have concluded that the rabbit skin infection model gave very similar results to the mouse model for infection at the same site
[<xref ref-type="bibr" rid="B4">4</xref>]. Nonetheless, testing of our PVL deletion mutant in a rabbit model may be warranted in future.</p></sec><sec><title>Genome sequencing of three additional ST93 isolates</title><p>We have previously fully sequenced and annotated the genome of ST93 strain JKD6159
[<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B23">23</xref>]. The differential virulence and exotoxin expression of some ST93 isolates compared to JKD6159 was then exploited by using whole genome sequencing and comparative genomics to determine the genetic basis for exotoxin expression in this clone. We selected the high expression strain TPS3104 and the low virulence and expression strains TPS3105 and TPS3106 to compare to JKD6159. <italic>De novo</italic> assembly of each of these strains resulted in ~700 contigs per isolate, with a genome length of 2.8 Mbp. The <italic>de novo</italic> assembly metrics are summarized in Additional file
<xref ref-type="supplementary-material" rid="S7">7</xref>. The contigs were aligned to JKD6159 using BLASTN, with some important differences demonstrated between the strains (Figure&#x000a0;
<xref ref-type="fig" rid="F4">4</xref>A). TPS3104 contained SCC<italic>mec</italic>IV and &#x003d5;SA2 with <italic>lukSF-PV</italic>; TPS3105 contained SCC<italic>mec</italic>IV but lacked &#x003d5;SA2 and <italic>lukSF-PV</italic>; TPS3106 contained SCC<italic>mec</italic>V, and &#x003d5;SA2 without <italic>lukSF-PV</italic>. In addition, read-mapping against the complete JKD6159 genome (chromosome and plasmid: 2,832,164&#x000a0;bp) was then employed to define a 2,720,685&#x000a0;bp core genome among these four isolates (96% of the JKD6159 genome), revealing 253 polymorphic nucleotide positions, some of which were common to two strains. A phylogeny was inferred that confirmed the close relationship among all isolates, with TPS3106 more distantly related to the others (Figure&#x000a0;
<xref ref-type="fig" rid="F4">4</xref>B). The unmapped reads from each isolate were also subjected to <italic>de novo</italic> assembly to identify DNA not present in JKD6159. TPS3104 and TPS3105 contained no new sequences, while TPS3106 contained 34&#x000a0;kb of additional DNA, predominantly spanning the SCC<italic>mec</italic>V region.</p><fig id="F4" position="float"><label>Figure 4</label><caption><p><bold>Whole genome sequence analysis and comparison of JKD6159 with other ST93 CA-MRSA isolates. (A)</bold> Circular diagram of the JKD6159, TPS3104, TPS3105 and TPS3106 chromosomes (from inner to outer circles). TPS3104, TPS3105 and TPS3106 contigs were mapped by BLASTN to JKD6159. TPS3104 contained SCC<italic>mec</italic>IV and &#x003d5;SA2 with <italic>lukSF-PV</italic>; TPS3105 contained SCC<italic>mec</italic>IV but lacked &#x003d5;SA2 and <italic>lukSF-PV</italic>; TPS3106 contained SCC<italic>mec</italic>V, and &#x003d5;SA2 without <italic>lukSF-PV</italic>. <bold>(B)</bold> ST93 <italic>S. aureus</italic> phylogeny inferred by split decomposition analysis from pairwise comparisons of the 253 variable nucleotide positions identified from the ST93 core chromosome of 2,720,685&#x000a0;bp. Figures indicate the number of nucleotide substitutions per branch. All nodes have 100% bootstrap support.</p></caption><graphic xlink:href="1471-2180-14-31-4"/></fig></sec><sec><title>Comparative genomics of ST93 and the importance of <italic>agr</italic> in the virulence of ST93 CA-MRSA</title><p>We next explored the contribution of specific mutations to the differential virulence of the ST93 strains. Using our read mapping approach described above, we compared the genome sequences of TPS3104, TPS3105 and TPS3106 with each other and with JKD6159. There were a number of single nucleotide polymorphisms (SNPs) and insertions and deletions (indels) differentiating the strains from JKD6159 (Additional files
<xref ref-type="supplementary-material" rid="S8">8</xref>,
<xref ref-type="supplementary-material" rid="S9">9</xref>,
<xref ref-type="supplementary-material" rid="S10">10</xref>). We searched for mutations in regulatory genes that could potentially explain the different virulence phenotypes of the strains. Notably, both avirulent ST93 strains, TPS3105 and TPS3106 contained mutations within the <italic>agr</italic> locus. We have since completed whole genome sequencing of TPS3151 and TPS3161 and found they contain predicted amino acid substitutions in AgrC that might disrupt <italic>agr</italic> function (Stinear <italic>et al</italic>., submitted). These isolates demonstrated low expression of Hla (Additional file
<xref ref-type="supplementary-material" rid="S3">3</xref>).</p><p>Additionally, TPS3106 also contained a mutation in a gene encoding a previously uncharacterized AraC/XylS family regulatory protein. This was also of particular interest as members of this class have been shown to contribute to the regulation of exotoxin expression
[<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>].</p><p>TPS3105 contained a frame-shift mutation within <italic>agrA</italic> (Sa_JKD6159 nucleotide 2096502) and a further substitution (G to A) within <italic>agrA</italic> at nucleotide 2096569), while TPS3106 contained an ~356&#x000a0;bp deletion spanning the <italic>agr</italic> effector molecule, RNAIII (deletion spanning nucleotides 2093372 to 2093728). These mutations suggested these isolates were <italic>agr</italic> deficient. To demonstrate that these changes explained the reduced exotoxin expression and loss of virulence in TPS3105 we repaired <italic>agrA</italic> using allelic exchange to create TPS3105<italic>r</italic> (the parental strain TPS3105 now containing an intact <italic>agrA</italic>)<italic>.</italic> Quantitative real time RT-PCR for <italic>RNAIII</italic> demonstrated that TPS3105<italic>r</italic> produced 325-fold more <italic>RNAIII</italic> than TPS3105. Virulence was also restored and TPS3105<italic>r</italic> caused greater weight loss, skin lesion area and CFU recovery from lesions compared to the parental strain TPS3105 (p&#x02009;&#x0003c;&#x02009;0.0001, Figure&#x000a0;
<xref ref-type="fig" rid="F5">5</xref>). There was no significant difference between JKD6159 and TPS3105<italic>r</italic> in all outcome measures in the mouse skin infection model (Figure&#x000a0;
<xref ref-type="fig" rid="F5">5</xref>). These experiments show that intact <italic>agr</italic> is essential for the virulence of ST93 CA-MRSA. The <italic>agrA</italic> repaired mutant of TPS3105, TPS3105<italic>r</italic> expressed significantly greater amounts of PSM&#x003b1;3 (p&#x02009;&#x0003c;&#x02009;0.0001) and Hla (p&#x02009;=&#x02009;0.0019), consistent with <italic>agr</italic> control of these virulence determinants (Figure&#x000a0;
<xref ref-type="fig" rid="F6">6</xref>). Thus, despite the genetic divergence of ST93 from other <italic>S. aureus</italic>[<xref ref-type="bibr" rid="B14">14</xref>], the molecular foundation of virulence for this CA-MRSA clone is similar in this respect to USA300
[<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B27">27</xref>] and other <italic>S. aureus</italic> strains
[<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>], where the importance of <italic>agr</italic> has been very well established.</p><fig id="F5" position="float"><label>Figure 5</label><caption><p><bold>The importance of </bold><bold><italic>agr </italic></bold><bold>and </bold><bold><italic>aryK </italic></bold><bold>in the virulence of ST93 CA-MRSA.</bold> Isogenic repaired <italic>agr</italic> mutant TPS3105<italic>r</italic> compared to TPS3105 and JKD6159, and JKD6159 compared with isogenic repaired AraC/XylS family regulator mutant (JKD6159_AraC<italic>r</italic>) in a BALB/c mouse skin infection assay. At least 10 mice were used for each bacterial strain. <bold>(A)</bold> Weight loss induced by intradermal infection with <italic>S. aureus</italic> strains is demonstrated as percentage loss of weight over 5&#x000a0;days. There was no difference between JKD6159 and TPS3105<italic>r</italic> in all outcome measures. TPS3105<italic>r</italic> infected mice had significantly increased weight loss compared to TPS3105 (p&#x02009;&#x0003c;&#x02009;0.0001). There was a small increase in weight loss in mice infected with JKD6159_AraC<italic>r</italic> compared to JKD6159 (p&#x02009;=&#x02009;0.0311). Data shown are mean weight loss and SEM. <bold>(B)</bold> Skin lesion area (mm<sup>2</sup>) at 5&#x000a0;days after infection in TPS3105<italic>r</italic> infected mice was significantly increased compared to TPS3105 (p&#x02009;&#x0003c;&#x02009;0.0001). Mice infected with JKD6159_AraC<italic>r</italic> had increased lesion area compared with JKD6159 (p&#x02009;&#x0003c;&#x02009;0.0001). Data shown are mean area and SEM. <bold>(C)</bold> Recovery of <italic>S. aureus</italic> (log CFU) from infected tissues at 5&#x000a0;days after infection from TPS3105r was significantly greater than from TPS 3105 infected mice (p&#x02009;&#x0003c;&#x02009;0.0001). There was no difference in <italic>S. aureus</italic> recovered from mice infected with JKD6159 and JKD6159_AraC<italic>r.</italic> Data shown are mean CFU and SEM. Note, *** p&#x02009;&#x0003c;&#x02009;0.001, * p&#x02009;&#x0003c;&#x02009;0.05.</p></caption><graphic xlink:href="1471-2180-14-31-5"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><p><bold><italic>In vitro </italic></bold><bold>PSM</bold>&#x003b1;<bold>3 and Hla expression of mutant </bold><bold><italic>S. aureus </italic></bold><bold>isolates.</bold> JKD6159 compared with JKD6159_AraC<italic>r.</italic> TPS3105 compared with TPS3105<italic>r</italic>. <bold>(A)</bold> PSM&#x003b1;3 expression measured by HPLC. JKD6159_AraC<italic>r</italic> expressed more PSM&#x003b1;3 than JKD6159 (p&#x02009;=&#x02009;0.0325). TPS3105<italic>r</italic> expressed more PSM&#x003b1;3 than TPS3105 (p&#x02009;&#x0003c;&#x02009;0.0001). Data shown are mean concentration (&#x003bc;g/ml), presented as vertical stacked bars and SEM. Deformylated PSM&#x003b1;3 is shown in grey bars. N-formylated PSM&#x003b1;3 is shown in white bars. <bold>(B)</bold> Hla expression measured by quantitative Western blot. There was a small but statistically significant increase in Hla production by JKD6159_AraC<italic>r</italic> (p&#x02009;=&#x02009;0.0473). TPS3105<italic>r</italic> expressed more Hla than TPS3105 (p&#x02009;=&#x02009;0.0019) Data shown are mean intensity of bands in arbitrary units and SEM. Note, *p&#x02009;&#x0003c;&#x02009;0.05, compared to JKD6159. Note also, <sup>###</sup>p&#x02009;&#x0003c;&#x02009;0.001 and <sup>##</sup>p&#x02009;&#x0003c;&#x02009;0.01, compared to TPS3105.</p></caption><graphic xlink:href="1471-2180-14-31-6"/></fig></sec><sec><title>The AraC/XylS regulator (AryK) enhanced Hla expression and virulence in ST93 CA-MRSA</title><p>The SNP at position 92551 in SAA6159_00084 introduced a premature stop codon and created a pseudogene within SAA6159_00084 in JDK6159, however the gene was intact in TPS3106. The intact version of this gene, which was also intact in 19 other publically available <italic>S. aureus</italic> genome sequences we examined, encodes a previously uncharacterized AraC/XylS family regulatory protein. While the virulence attenuation in TPS3106 was likely a direct result of the <italic>agr</italic> deficiency, we also wanted to determine if the novel regulator mutation in SAA6159_00084 impacted the virulence in ST93 <italic>S. aureus</italic>.</p><p>To test the hypothesis that SAA6159_00084 encoded a regulator of virulence, we repaired the premature stop codon in SAA6159_00084 in JKD6159 using allelic exchange to generate strain JKD6159_AraC<italic>r.</italic> To confirm we had not introduced additional DNA changes during allelic exchange we sequenced the whole genome of JKD6159_AraC<italic>r</italic> and found no additional mutations (35&#x000d7; coverage). JKD6159_AraC<italic>r</italic> encoding an intact copy of SAA6159_00084 demonstrated a modest, but significant increase in virulence as indicated by lesion size (p&#x02009;&#x0003c;&#x02009;0.0001) and weight loss in the mouse skin infection assay (p&#x02009;=&#x02009;0.0311, Figure&#x000a0;
<xref ref-type="fig" rid="F5">5</xref>), suggesting that this protein is a positive regulator of virulence in CA-MRSA strains. JKD6159_AraC<italic>r</italic> expressed more PSM&#x003b1;3 (p&#x02009;=&#x02009;0.0325) and Hla (p&#x02009;=&#x02009;0.0473) than its parental strain JKD6159 that was consistent with an increase mouse skin lesion size (Figure&#x000a0;
<xref ref-type="fig" rid="F6">6</xref>). We propose the name <italic>aryK</italic> for SAA6159_00084 (<bold>Ar</bold>aC famil<bold>y</bold>-li<bold>k</bold>e gene).</p></sec><sec><title>RNAseq demonstrates global regulatory impact of AryK</title><p>To investigate the regulatory impact of AryK, RNAseq was performed using RNA extracted from stationary phase cultures (Figure&#x000a0;
<xref ref-type="fig" rid="F7">7</xref>). This growth phase was selected as we reasoned that AryK might be interacting with <italic>agr</italic> and thus any impacts on Hla expression would be greatest at this time. A small number of virulence-associated loci were down regulated in the <italic>aryK</italic> mutant (JKD6159), including beta-type phenol soluble modulins (SAA6159_01024 and SAA6159_01025), and the virulence regulator <italic>saeS</italic>. However, the most dramatic and significant transcriptional changes were found in genes involved in central metabolic functions. Using the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis (
<ext-link ext-link-type="uri" xlink:href="http://www.genome.jp">http://www.genome.jp</ext-link>)
[<xref ref-type="bibr" rid="B30">30</xref>] the major pathways where differential transcription occurred were down regulation of genes linked to purine metabolism (<italic>purK, purS, purQ, purL, purF</italic>), valine, leucine and isoleucine biosynthesis (<italic>leuA</italic>, <italic>leuB</italic>, <italic>leuC</italic>), and oligopeptide transport (<italic>opp3C, opp3D, opp3F, opp3A</italic>). In contrast up regulation of genes encoding cation transport systems (<italic>mnhB_1, mnhC_1, mnhD_1, mnhF_1, mnhG_1</italic>) was found.</p><fig id="F7" position="float"><label>Figure 7</label><caption><p><bold>Heatmap of RNA Sequencing comparing JKD6159 (</bold><bold><italic>aryK </italic></bold><bold>inactive) to JKD6159_AraC</bold><bold><italic>r </italic></bold><bold>(</bold><bold><italic>aryK </italic></bold><bold>intact).</bold> RNA seq was performed in duplicate from stationary phase cultures. This heatmap, clustered on expression profiles, was created based on log<sub>2</sub> transformed counts to identify consistent changes in expression profiles between strains. To be included in the heat map, genes were required to have at least 1000 counts (reads), totaled over all samples, where the standard deviation of log<sub>2</sub> expression differences had to exceed two. The heatmap highlights significant <italic>aryK</italic>-dependent changes, in particular genes involved in the regulation of central metabolic functions.</p></caption><graphic xlink:href="1471-2180-14-31-7"/></fig><p>Here, we have clearly demonstrated that <italic>agr</italic> is the major "on-off" switch for virulence in ST93 CA-MRSA, but we also found that other genetic changes are impacting virulence gene regulation in a clone-specific manner. We speculate that the inactivation of <italic>aryK</italic> may have been an evolutionary response by ST93 CA-MRSA to modulate or fine-tune the amount of Hla and other factors required for host persistence. There are six AraC/XylS family regulators in <italic>S. aureus</italic> (SA0097, SA0215, SA0622, SA1337, SA2092, SA2169; <italic>S. aureus</italic> strain N315 locus tags). Two of these, Rbf (SA0622) and Rsp (SA2169) have been studied and demonstrated in other <italic>S. aureus</italic> strains to regulate biofilm formation and modulate expression of surface-associated proteins
[<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B31">31</xref>]. In contrast, we found that <italic>aryK</italic> increases Hla expression and virulence, acting as a positive regulator of virulence by directly or indirectly upregulating exotoxin expression, without an apparent effect on <italic>agr</italic> expression in stationary phase.</p></sec></sec><sec sec-type="conclusions"><title>Conclusions</title><p>In this study, we have obtained insights into the genetic basis for the increased virulence of ST93 by using a combination of comparative and functional genomics. We have demonstrated the key role of Hla and <italic>agr</italic> and shown how an additional novel regulatory gene, <italic>aryK</italic> by a loss-of-function point mutation, is modulating virulence in this clone. Quantification of exotoxin expression in a larger collection of ST93 strains demonstrated that the findings in strain JKD6159 are relevant to the majority of the ST93 population isolated from around Australia as exotoxin expression in JKD6159 is representative of most of the ST93 population. Our study highlights the power of comparative genomics to uncover new regulators of virulence but it also shows the complex nature of these changes even in closely related bacterial populations. Careful strain selection, detailed comparative genomics analyses, and functional genomic studies by creating multiple genetic changes in one strain will be required to gain a full insight into the genetic basis for the emergence and hypervirulence of ST93 CA-MRSA.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Ethics statement</title><p>This study was performed in accordance with the Australian Prevention of Cruelty to Animals Act 1986 and the Australian code of practice for the care and use of animals for scientific purposes. The protocol was approved by the Animal Ethics Committee of the University of Melbourne (Permit Number: 0911248.2).</p></sec><sec><title>Bacterial strains and culture</title><p>Bacterial strains used in this study are summarized in Table&#x000a0;
<xref ref-type="table" rid="T1">1</xref> (international clone collection) and Additional file
<xref ref-type="supplementary-material" rid="S1">1</xref> (ST93 strain collection), and include the ST93 reference strains JKD6159, USA300 strain FPR3757
[<xref ref-type="bibr" rid="B19">19</xref>], ST30 strain JKD6177, and the HA-MRSA ST239 clone JDK6009
[<xref ref-type="bibr" rid="B20">20</xref>], as well as 58 additional ST93 collected from around Australia and previously reported
[<xref ref-type="bibr" rid="B17">17</xref>]. For all experiments except exotoxin expression bacteria were grown in brain heart infusion broth (BHI, Oxoid). For the mouse skin infection assay, <italic>S. aureus</italic> were harvested at the stationary phase of growth after 18&#x000a0;hours incubation (OD<sub>600</sub>&#x02009;~&#x02009;2.0), washed, diluted and resuspended in PBS. The bacterial inoculum (CFU) and viable counts were determined by plating onto BHI agar and colony enumeration.</p><p>For LukF-PV expression experiments, bacteria were grown in CCY media (3% yeast extract (Oxoid), 2% Bacto Casamino Acids (Difco), 2.3% sodium pyruvate (Sigma-Aldrich), 0.63% Na<sub>2</sub>HPO<sub>4</sub>, 0.041% KH<sub>2</sub>PO<sub>4</sub>, pH&#x000a0;6.7). For &#x003b1;-hemolysin (Hla) and PSM&#x003b1;3 expression experiments, bacteria were grown in tryptone soy broth (TSB, Oxoid). Overnight cultures were diluted 1:100 into fresh media and then incubated at 37&#x000b0;C with shaking (180&#x000a0;rpm) until stationary phase was achieved. For LukF-PV detection, isolates were cultured for 8&#x000a0;hours (OD<sub>600</sub> ~ 1.8); for Hla detection, isolates were cultured for approximately 3&#x000a0;hours (OD<sub>600</sub> ~ 1.8); and for PSM&#x003b1;3 detection, isolates were cultured for 24&#x000a0;hours (OD<sub>600</sub> ~ 2.0). Culture supernatants were harvested by centrifugation and filter sterilized. These were performed in at least triplicate for each <italic>S. aureus</italic> strain.</p></sec><sec><title>Detection of LukF-PV and Hla by western blotting</title><p>Trichloroacetic acid was added to culture supernatants and incubated at 4&#x000b0;C overnight. Precipitates were then harvested by centrifugation, washed with acetone, air-dried and solubilized in a SDS and 2-mercaptoethanol containing sample buffer. The proteins were separated on 12% SDS-PAGE. A peptide sequence specific to LukF-PV, HWIGNNYKDENRATHT was synthesized and HRP conjugated polyclonal chicken IgY was raised against this peptide (Genscript). This antibody was used to detect LukF-PV with enhanced chemiluminescence. Images generated from the western blots were quantitated using GS800 Calibrated Densitometer (BioRad) and Image J
[<xref ref-type="bibr" rid="B32">32</xref>].</p><p>Hla was detected using a polyclonal rabbit anti-Hla (Sigma-Aldrich), in buffer containing 20&#x000a0;mM DEPC to inhibit non-specific protein A binding and HRP conjugated sheep anti-rabbit secondary antibody (Millipore) with enhanced chemiluminescence detection
[<xref ref-type="bibr" rid="B33">33</xref>]. For comparison of JKD6159 versus international clone collection (Table&#x000a0;
<xref ref-type="table" rid="T1">1</xref>), images generated from the Hla western blots were quantitated using GS800 Calibrated Densitometer (BioRad) and Image J
[<xref ref-type="bibr" rid="B32">32</xref>].</p><p>Subsequently, for comparison of JKD6159 and other ST93 strains (Table&#x000a0;
<xref ref-type="table" rid="T1">1</xref>), detection of chemiluminescence was performed using the MF-ChemiBIS 3.2 platform (DNR Bioimaging systems). Quantitation was performed using Image J
[<xref ref-type="bibr" rid="B32">32</xref>].</p></sec><sec><title>Detection of PSM&#x003b1;3 expression</title><p>HPLC chromatography was performed on an Agilent Technology 1200 Series system with an analytical Agilent Eclipse XDB-C18 (4.6&#x000a0;mm&#x02009;&#x000d7;&#x02009;150&#x000a0;mm) column. A water/acetonitrile gradient (0.1% trifluoroacetic acid) from 0 &#x02013; 100% acetonitrile over 28&#x000a0;min at a flow rate of 1&#x000a0;mL/min was used. The total run time was 32&#x000a0;min, and peaks were quantified at a wavelength of 214&#x000a0;nm. The deformylated and formylated form of PSM&#x003b1;3 MEFVAKLFKFFKDLLGKFLGNN was identified in the <italic>S. aureus</italic> TSB culture supernatants by comparison of their retention times to a commercially synthesized PSM&#x003b1;3 standard (GenScript) and by spiking the samples with the synthesized standards. The identity of the deformylated peptide present in the samples was confirmed by analysing collected fractions by ESI-MS. There was only one peptide present in this fraction; the deformylated form of PSM&#x003b1;3. In contrast, other peptides were observed in the fractions of USA300, JKD6272, TPS3104, TPS3105<italic>r</italic>, and JKD6159_AraC<italic>r</italic> containing the N-formylated form of PSM&#x003b1;3. In these cases, the percentage of N-formylated PSM&#x003b1;3 peptide was determined using the total ion count of the major peaks in the ESI-MS and the peak area of the HPLC chromatogram was adjusted accordingly. The concentrations of the deformylated and formylated forms of PSM&#x003b1;3 were determined by comparison of their peak areas to those of the synthesized standards. The standard curves were constructed in the concentration range of 6.2 &#x02013; 100&#x000a0;&#x003bc;g/ mL and were linear over this range.</p></sec><sec><title>DNA methods, molecular techniques and construction of mutants</title><p>DNA was extracted using the GenElute kit according to the manufacturer&#x02019;s instructions (Sigma-Aldrich). A <italic>lukSF-PV</italic> knockout, <italic>hla</italic> knockout and a repaired <italic>agrA</italic> of TPS3105 were generated according to the published method
[<xref ref-type="bibr" rid="B34">34</xref>]. For the knockouts, flanking sequences were amplified and ligated prior to cloning with pKOR1. For allelic replacement to generate TPS3105<italic>r,</italic> a PCR product of <italic>agrA</italic> from JKD6159 was cloned with pKOR1. For allelic replacement JKD6159_AraC<italic>r,</italic> a PCR product of this AraC regulator from TPS3106 was cloned with pKOR1. The deletion of the whole <italic>psm&#x003b1;</italic> locus in JKD6159, chromosomal restoration of <italic>psm&#x003b1;</italic> in JKD6159&#x02206;<italic>psm&#x003b1;</italic> and the restoration of Hla expression in JKD6159&#x02206;<italic>hla</italic> were conducted using the pIMAY protocol described by Monk et al.
[<xref ref-type="bibr" rid="B35">35</xref>]. Knockout and restoration amplimers were cloned into pIMAY by SLIC
[<xref ref-type="bibr" rid="B36">36</xref>]. The primers used are listed in Additional file
<xref ref-type="supplementary-material" rid="S11">11</xref>. The knockout and restoration clones were confirmed by PCR and Sanger sequencing of the mutated locus. Mutations were further validated with functional assays of activity, which included sheep blood hemolysis, western blot, and/or HPLC.</p></sec><sec><title>Mouse skin infection assay</title><p>Mice were infected with <italic>S. aureus</italic> as previously described
[<xref ref-type="bibr" rid="B14">14</xref>]. Briefly, six-week-old female BALB/c mice were infected by intradermal injection with 10<sup>8</sup>&#x000a0;CFU of <italic>S. aureus.</italic> Mice were assessed and weighed daily for five days. Mice were culled on the 5th day and lesion size measured and CFU recovered from infected tissues by homogenization and colony enumeration on BHI. For each <italic>S. aureus</italic> strain, at least 10 mice were assessed.</p></sec><sec><title>Genome sequencing</title><p>Genome sequences for three ST93 strains (TPS3104, TPS3105, TPS3106) were obtained from an Illumina GAIIx analyzer using 100&#x000a0;bp paired-end chemistry with a mean fold coverage of 331&#x000d7;. Genome sequencing of the two laboratory-induced mutants JKD6159&#x02206;<italic>hla</italic> (TPS3265) and JKD6159_AraC<italic>r</italic> (TPS3268) was performed using Ion Torrent sequencing technology.</p></sec><sec><title>Comparative genomics</title><p>A read mapping approach was used to compare the sequences from all isolates used in this study, as previously described
[<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B37">37</xref>]. Briefly, the reads from all genomes were aligned to the JKD6159 reference using SHRiMP 2.0
[<xref ref-type="bibr" rid="B38">38</xref>]. SNPs were identified using Nesoni v0.60 [
<ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.net.au">http://www.bioinformatics.net.au</ext-link>]. Using the whole genome sequence of JKD6159 as a reference, a global SNP analysis was performed, and allelic variability at any nucleotide position was tallied to generate a global SNP analysis for every genome compared to JKD6159.</p></sec><sec><title>Quantitative RT-PCR for RNAIII expression</title><p>To investigate activity of the <italic>agr</italic> locus (RNAIII) qRT-PCR was performed for RNAIII as previously described
[<xref ref-type="bibr" rid="B37">37</xref>]. Briefly, RNA was prepared as previously described with two on-column DNase I digestion steps and cDNA synthesis using SuperScript II reverse transcriptase (Invitrogen). Relative expression was determined as previously described and was normalised against <italic>gyrB</italic>. Results were obtained from 3 biological replicates each performed in triplicate.</p></sec><sec><title>RNA sequencing</title><p><italic>Staphylococcus aureus</italic> strains JKD6159 and JKD6159_AraC<italic>r</italic> were grown to early stationary culture as described above. For RNA protection, 0.5 volumes of RNAlater&#x000ae; RNA stabilization reagent (Qiagen) was added immediately to the liquid culture and allowed to incubate with the bacterial suspension for 15&#x000a0;minutes at room temperature. Cells were pelleted at 5,000&#x02009;&#x000d7;&#x02009;g for 5&#x000a0;minutes followed by RNA extraction using RNeasy mini kit (Qiagen) and two rounds of DNase I digestion (Qiagen) according to the manufacturer&#x02019;s instruction. RNA concentration was quantified using Qubit&#x000ae; 2.0 Fluorometer and RNA quality assessed using Agilent 2100 Bioanalyzer. Ten &#x003bc;g of total RNA from the stationary growth phase with RNA intergrity number (RIN) greater than 7 was used in RNA-seq. Ribosomal depletion, cDNA library preparation and pair ended sequencing using HiSeq2000 sequencing platform was performed by Beijing Genome Institute (Hong Kong, China). RNAseq was performed on two biological samples for each strain.</p><p>RNAseq reads were mapped onto the JKD6159 reference genome
[<xref ref-type="bibr" rid="B23">23</xref>], using SHRiMP 2.2.2
[<xref ref-type="bibr" rid="B39">39</xref>]. Alignment to CDS features from each biological replicate of each strain provided counts that were a measure of mRNA levels. Counts were normalized using the trimmed-mean normalization function in edgeR, part of the BioConductor package
[<xref ref-type="bibr" rid="B40">40</xref>]. A heat map was created based on log<sub>2</sub> transformed counts to identify consistent changes in expression profiles between strains. To be included in the heat map, genes were required to have at least 1000 counts, totaled over all samples, where and the standard deviation of the log<sub>2</sub> expression levels had to exceed two.</p></sec><sec><title>Statistical analysis</title><p>Percentage mouse weight change at day 5, viable counts of <italic>S. aureus</italic> in mouse tissues and skin lesion area of each isolate, Hla, LukF-PV and PSM&#x003b1;3 expression versus JKD6159 were analyzed using an unpaired t test. A similar analysis was used to analyze virulence outcome measures and exotoxin expression between TPS3105 and TPS3105<italic>r</italic>. (There was no difference in results when Bonferonni analysis was performed). All analyses were performed using Prism 5 for Macintosh v5.0b (GraphPad Software Inc.).</p></sec><sec><title>Availability of supporting data</title><p>The data sets supporting the results of this article are in the NCBI Sequence Read Archive under study accession SRP004474.2 and the NCBI BioProject Archive under study accession PRJNA217697.</p></sec></sec><sec><title>Competing interest</title><p>No author has any competing interests to declare.</p></sec><sec><title>Authors&#x02019; contributions</title><p>Conceived the project, TPS, BPH, KYLC, JKD; performed the experiments, KYLC, IRM, YHL, JLP, GWC, JS, KLT; analysed the data, KYLC, YHL, TPS, BPH, TS, KLT; wrote the manuscript, KYLC, BPH, TPS. All authors read and approved the final manuscript.</p></sec><sec><title>Authors&#x02019; information</title><p>Timothy P. Stinear and Benjamin P. Howden are the Joint Senior Authors.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="S1"><caption><title>Additional file 1</title><p><bold>
<italic>Staphylococcus aureus </italic>
</bold><bold>ST93 strains used in this study.</bold></p></caption><media xlink:href="1471-2180-14-31-S1.xlsx"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S2"><caption><title>Additional file 2</title><p><bold>Expression of PSM&#x003b1;3 by ST93 strains and USA300.</bold> (A) Expression of deformylated PSM&#x003b1;3. (B) Expression of N-formylated PSM&#x003b1;3. Data shown are mean concentration (&#x003bc;g/ml) and SEM.</p></caption><media xlink:href="1471-2180-14-31-S2.tiff"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S3"><caption><title>Additional file 3</title><p><bold>Expression of Hla by ST93 strains and USA300.</bold> Hla expression measured by quantitative Western blot. Data shown are mean intensity of bands in arbitrary units and SEM.</p></caption><media xlink:href="1471-2180-14-31-S3.tiff"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S4"><caption><title>Additional file 4</title><p><bold>Hla Western Blot of JKD6159, JKD6159&#x02206;</bold><bold>
<italic>hla</italic>
</bold><bold> and JKD6159&#x02206;</bold><bold>
<italic>hla r </italic>
</bold><bold>(A) Western Blot demonstrating that JKD6159&#x02206;</bold><bold>
<italic>hla </italic>
</bold><bold>does not express Hla by Western Blot and that complementation of this mutant (JKD6159&#x02206;</bold><bold>
<italic>hla r</italic>
</bold><bold>) </bold><bold>results in restoration of Hla expression.</bold> (B) Arrangement of PCR primers used PCR screen of JKD6159&#x02206;<italic>hla</italic> and JKD6159&#x02206;<italic>hla r.</italic> (C) PCR screen of 25 randomly selected <italic>S. aureus</italic> colonies obtained from two mice (mouse 4 and mouse 7) post skin infection with JKD6159&#x02206;<italic>hla r.</italic> The PCR primers used flank the region deleted in <italic>hla</italic> for the mutant and show incomplete penetration of the bacterial population with the repaired version of <italic>hla</italic> (17/25 with an intact allele for mouse 4 and 21/25 for mouse 7), thereby explaining the inability of the repaired mutant to fully restore the virulence phenotype in this infection model.</p></caption><media xlink:href="1471-2180-14-31-S4.tiff"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S5"><caption><title>Additional file 5</title><p><bold>Detection of formylated PSM&#x003b1;3 in JKD6159, JKD6159&#x02206;</bold><bold>
<italic>psm&#x003b1;</italic>
</bold><bold> and JKD6159&#x02206;</bold><bold>
<italic>psm&#x003b1; r </italic>
</bold><bold>by HPLC of culture filtrates.</bold> JKD6159&#x02206;<italic>psm&#x003b1;</italic> did not produce formylated PSM&#x003b1;3. Complementation of this strain resulted in restoration of formylated PSM&#x003b1;3 expression. In all strains &#x003b4;-toxin expression was maintained.</p></caption><media xlink:href="1471-2180-14-31-S5.tiff"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S6"><caption><title>Additional file 6</title><p><bold>LukF-PV Western Blot of JKD6159 and JKD6159&#x02206;</bold><bold>
<italic>lukSF-PV.</italic>
</bold> Western Blot demonstrating that JKD6159&#x02206;<italic>lukSF-PV</italic> does not express LukF-PV.</p></caption><media xlink:href="1471-2180-14-31-S6.tiff"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S7"><caption><title>Additional file 7</title><p><bold>Table of </bold><bold>
<italic>de novo </italic>
</bold><bold>assembly characteristics for </bold><bold>
<italic>S. aureus</italic>
</bold><bold> strains TPS3104, TPS3105 and TPS3106.</bold></p></caption><media xlink:href="1471-2180-14-31-S7.docx"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S8"><caption><title>Additional file 8</title><p>Table of single nucleotide differences between JKD6159 and TPS3104.</p></caption><media xlink:href="1471-2180-14-31-S8.xlsx"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S9"><caption><title>Additional file 9</title><p>Table of single nucleotide differences between JKD6159 and TPS3105.</p></caption><media xlink:href="1471-2180-14-31-S9.xlsx"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S10"><caption><title>Additional file 10</title><p>Table of single nucleotide differences between JKD6159 and TPS3106.</p></caption><media xlink:href="1471-2180-14-31-S10.xlsx"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S11"><caption><title>Additional file 11</title><p>Table of primers used in this study.</p></caption><media xlink:href="1471-2180-14-31-S11.docx"><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><sec><title>Acknowledgements</title><p>We thank Kirstie Mangas and Brian Howden for expert technical assistance.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>David</surname><given-names>MZ</given-names></name><name><surname>Daum</surname><given-names>RS</given-names></name><article-title>Community-associated methicillin-resistant <italic>Staphylococcus aureus</italic>: epidemiology and clinical consequences of an emerging epidemic</article-title><source>Clin Microbiol Rev</source><year>2010</year><volume>23</volume><issue>3</issue><fpage>616</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.1128/CMR.00081-09</pub-id><?supplied-pmid 20610826?><pub-id pub-id-type="pmid">20610826</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Loffler</surname><given-names>B</given-names></name><name><surname>Hussain</surname><given-names>M</given-names></name><name><surname>Grundmeier</surname><given-names>M</given-names></name><name><surname>Bruck</surname><given-names>M</given-names></name><name><surname>Holzinger</surname><given-names>D</given-names></name><name><surname>Varga</surname><given-names>G</given-names></name><name><surname>Roth</surname><given-names>J</given-names></name><name><surname>Kahl</surname><given-names>BC</given-names></name><name><surname>Proctor</surname><given-names>RA</given-names></name><name><surname>Peters</surname><given-names>G</given-names></name><article-title><italic>Staphylococcus aureus</italic> Panton-Valentine leukocidin is a very potent cytotoxic factor for human neutrophils</article-title><source>PLoS Pathog</source><year>2010</year><volume>6</volume><issue>1</issue><fpage>e1000715</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1000715</pub-id><?supplied-pmid 20072612?><pub-id pub-id-type="pmid">20072612</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Diep</surname><given-names>BA</given-names></name><name><surname>Chan</surname><given-names>L</given-names></name><name><surname>Tattevin</surname><given-names>P</given-names></name><name><surname>Kajikawa</surname><given-names>O</given-names></name><name><surname>Martin</surname><given-names>TR</given-names></name><name><surname>Basuino</surname><given-names>L</given-names></name><name><surname>Mai</surname><given-names>TT</given-names></name><name><surname>Marbach</surname><given-names>H</given-names></name><name><surname>Braughton</surname><given-names>KR</given-names></name><name><surname>Whitney</surname><given-names>AR</given-names></name><etal/><article-title>Polymorphonuclear leukocytes mediate <italic>Staphylococcus aureus</italic> Panton-Valentine leukocidin-induced lung inflammation and injury</article-title><source>Proc Natl Acad Sci U S A</source><year>2010</year><volume>107</volume><issue>12</issue><fpage>5587</fpage><lpage>5592</lpage><pub-id pub-id-type="doi">10.1073/pnas.0912403107</pub-id><?supplied-pmid 20231457?><pub-id pub-id-type="pmid">20231457</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Kobayashi</surname><given-names>SD</given-names></name><name><surname>Malachowa</surname><given-names>N</given-names></name><name><surname>Whitney</surname><given-names>AR</given-names></name><name><surname>Braughton</surname><given-names>KR</given-names></name><name><surname>Gardner</surname><given-names>DJ</given-names></name><name><surname>Long</surname><given-names>D</given-names></name><name><surname>Bubeck Wardenburg</surname><given-names>J</given-names></name><name><surname>Schneewind</surname><given-names>O</given-names></name><name><surname>Otto</surname><given-names>M</given-names></name><name><surname>Deleo</surname><given-names>FR</given-names></name><article-title>Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection</article-title><source>J Infect Dis</source><year>2011</year><volume>204</volume><issue>6</issue><fpage>937</fpage><lpage>941</lpage><pub-id pub-id-type="doi">10.1093/infdis/jir441</pub-id><?supplied-pmid 21849291?><pub-id pub-id-type="pmid">21849291</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Lipinska</surname><given-names>U</given-names></name><name><surname>Hermans</surname><given-names>K</given-names></name><name><surname>Meulemans</surname><given-names>L</given-names></name><name><surname>Dumitrescu</surname><given-names>O</given-names></name><name><surname>Badiou</surname><given-names>C</given-names></name><name><surname>Duchateau</surname><given-names>L</given-names></name><name><surname>Haesebrouck</surname><given-names>F</given-names></name><name><surname>Etienne</surname><given-names>J</given-names></name><name><surname>Lina</surname><given-names>G</given-names></name><article-title>Panton-Valentine leukocidin does play a role in the early stage of <italic>Staphylococcus aureus</italic> skin infections: a rabbit model</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><issue>8</issue><fpage>e22864</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0022864</pub-id><?supplied-pmid 21850240?><pub-id pub-id-type="pmid">21850240</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Diep</surname><given-names>BA</given-names></name><name><surname>Villaruz</surname><given-names>AE</given-names></name><name><surname>Braughton</surname><given-names>KR</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>DeLeo</surname><given-names>FR</given-names></name><name><surname>Chambers</surname><given-names>HF</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Otto</surname><given-names>M</given-names></name><article-title>Evolution of virulence in epidemic community-associated methicillin-resistant <italic>Staphylococcus aureus</italic></article-title><source>Proc Natl Acad Sci U S A</source><year>2009</year><volume>106</volume><issue>14</issue><fpage>5883</fpage><lpage>5888</lpage><pub-id pub-id-type="doi">10.1073/pnas.0900743106</pub-id><?supplied-pmid 19293374?><pub-id pub-id-type="pmid">19293374</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Cheung</surname><given-names>GY</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Joo</surname><given-names>HS</given-names></name><name><surname>Deleo</surname><given-names>FR</given-names></name><name><surname>Otto</surname><given-names>M</given-names></name><article-title>Comparative analysis of virulence and toxin expression of global community-associated methicillin-resistant <italic>Staphylococcus aureus</italic> strains</article-title><source>J Infect Dis</source><year>2010</year><volume>202</volume><issue>12</issue><fpage>1866</fpage><lpage>1876</lpage><pub-id pub-id-type="doi">10.1086/657419</pub-id><?supplied-pmid 21050125?><pub-id pub-id-type="pmid">21050125</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Bhakdi</surname><given-names>S</given-names></name><name><surname>Tranum-Jensen</surname><given-names>J</given-names></name><article-title>Alpha-toxin of <italic>Staphylococcus aureus</italic></article-title><source>Microbiol Rev</source><year>1991</year><volume>55</volume><issue>4</issue><fpage>733</fpage><lpage>751</lpage><?supplied-pmid 1779933?><pub-id pub-id-type="pmid">1779933</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Bubeck Wardenburg</surname><given-names>J</given-names></name><name><surname>Bae</surname><given-names>T</given-names></name><name><surname>Otto</surname><given-names>M</given-names></name><name><surname>Deleo</surname><given-names>FR</given-names></name><name><surname>Schneewind</surname><given-names>O</given-names></name><article-title>Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in <italic>Staphylococcus aureus</italic> pneumonia</article-title><source>Nat Med</source><year>2007</year><volume>13</volume><issue>12</issue><fpage>1405</fpage><lpage>1406</lpage><pub-id pub-id-type="doi">10.1038/nm1207-1405</pub-id><?supplied-pmid 18064027?><pub-id pub-id-type="pmid">18064027</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Kennedy</surname><given-names>AD</given-names></name><name><surname>Bubeck Wardenburg</surname><given-names>J</given-names></name><name><surname>Gardner</surname><given-names>DJ</given-names></name><name><surname>Long</surname><given-names>D</given-names></name><name><surname>Whitney</surname><given-names>AR</given-names></name><name><surname>Braughton</surname><given-names>KR</given-names></name><name><surname>Schneewind</surname><given-names>O</given-names></name><name><surname>DeLeo</surname><given-names>FR</given-names></name><article-title>Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model</article-title><source>J Infect Dis</source><year>2010</year><volume>202</volume><issue>7</issue><fpage>1050</fpage><lpage>1058</lpage><pub-id pub-id-type="doi">10.1086/656043</pub-id><?supplied-pmid 20726702?><pub-id pub-id-type="pmid">20726702</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Braughton</surname><given-names>KR</given-names></name><name><surname>Kretschmer</surname><given-names>D</given-names></name><name><surname>Bach</surname><given-names>TH</given-names></name><name><surname>Queck</surname><given-names>SY</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Kennedy</surname><given-names>AD</given-names></name><name><surname>Dorward</surname><given-names>DW</given-names></name><name><surname>Klebanoff</surname><given-names>SJ</given-names></name><name><surname>Peschel</surname><given-names>A</given-names></name><etal/><article-title>Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA</article-title><source>Nat Med</source><year>2007</year><volume>13</volume><issue>12</issue><fpage>1510</fpage><lpage>1514</lpage><pub-id pub-id-type="doi">10.1038/nm1656</pub-id><?supplied-pmid 17994102?><pub-id pub-id-type="pmid">17994102</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Cheung</surname><given-names>GY</given-names></name><name><surname>Duong</surname><given-names>AC</given-names></name><name><surname>Otto</surname><given-names>M</given-names></name><article-title>Direct and synergistic hemolysis caused by <italic>Staphylococcus</italic> phenol-soluble modulins: implications for diagnosis and pathogenesis</article-title><source>Microbes Infect</source><year>2012</year><volume>14</volume><issue>4</issue><fpage>380</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2011.11.013</pub-id><?supplied-pmid 22178792?><pub-id pub-id-type="pmid">22178792</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Coombs</surname><given-names>GW</given-names></name><name><surname>Nimmo</surname><given-names>GR</given-names></name><name><surname>Pearson</surname><given-names>JC</given-names></name><name><surname>Christiansen</surname><given-names>KJ</given-names></name><name><surname>Bell</surname><given-names>JM</given-names></name><name><surname>Collignon</surname><given-names>PJ</given-names></name><name><surname>McLaws</surname><given-names>ML</given-names></name><collab>Resistance AGfA</collab><article-title>Prevalence of MRSA strains among <italic>Staphylococcus aureus</italic> isolated from outpatients, 2006</article-title><source>Commun Dis Intell</source><year>2009</year><volume>33</volume><issue>1</issue><fpage>10</fpage><lpage>20</lpage></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Chua</surname><given-names>KY</given-names></name><name><surname>Seemann</surname><given-names>T</given-names></name><name><surname>Harrison</surname><given-names>PF</given-names></name><name><surname>Monagle</surname><given-names>S</given-names></name><name><surname>Korman</surname><given-names>TM</given-names></name><name><surname>Johnson</surname><given-names>PD</given-names></name><name><surname>Coombs</surname><given-names>GW</given-names></name><name><surname>Howden</surname><given-names>BO</given-names></name><name><surname>Davies</surname><given-names>JK</given-names></name><name><surname>Howden</surname><given-names>BP</given-names></name><etal/><article-title>The dominant Australian community-acquired methicillin-resistant <italic>Staphylococcus aureus</italic> clone ST93-IV [2B] is highly virulent and genetically distinct</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><issue>10</issue><fpage>e25887</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0025887</pub-id><?supplied-pmid 21991381?><pub-id pub-id-type="pmid">21991381</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Tong</surname><given-names>SY</given-names></name><name><surname>Sharma-Kuinkel</surname><given-names>BK</given-names></name><name><surname>Thaden</surname><given-names>JT</given-names></name><name><surname>Whitney</surname><given-names>AR</given-names></name><name><surname>Yang</surname><given-names>SJ</given-names></name><name><surname>Mishra</surname><given-names>NN</given-names></name><name><surname>Rude</surname><given-names>T</given-names></name><name><surname>Lilliebridge</surname><given-names>RA</given-names></name><name><surname>Selim</surname><given-names>MA</given-names></name><name><surname>Ahn</surname><given-names>SH</given-names></name><etal/><article-title>Virulence of endemic nonpigmented northern Australian <italic>Staphylococcus aureus</italic> clone (clonal complex 75, <italic>S. argenteus</italic>) is not augmented by staphyloxanthin</article-title><source>J Infect Dis</source><year>2013</year><volume>208</volume><issue>3</issue><fpage>520</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1093/infdis/jit173</pub-id><?supplied-pmid 23599317?><pub-id pub-id-type="pmid">23599317</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>Labandeira-Rey</surname><given-names>M</given-names></name><name><surname>Couzon</surname><given-names>F</given-names></name><name><surname>Boisset</surname><given-names>S</given-names></name><name><surname>Brown</surname><given-names>EL</given-names></name><name><surname>Bes</surname><given-names>M</given-names></name><name><surname>Benito</surname><given-names>Y</given-names></name><name><surname>Barbu</surname><given-names>EM</given-names></name><name><surname>Vazquez</surname><given-names>V</given-names></name><name><surname>Hook</surname><given-names>M</given-names></name><name><surname>Etienne</surname><given-names>J</given-names></name><etal/><article-title><italic>Staphylococcus aureus</italic> Panton-Valentine leukocidin causes necrotizing pneumonia</article-title><source>Science</source><year>2007</year><volume>315</volume><issue>5815</issue><fpage>1130</fpage><lpage>1133</lpage><pub-id pub-id-type="doi">10.1126/science.1137165</pub-id><?supplied-pmid 17234914?><pub-id pub-id-type="pmid">17234914</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Coombs</surname><given-names>GW</given-names></name><name><surname>Goering</surname><given-names>RV</given-names></name><name><surname>Chua</surname><given-names>KY</given-names></name><name><surname>Monecke</surname><given-names>S</given-names></name><name><surname>Howden</surname><given-names>BP</given-names></name><name><surname>Stinear</surname><given-names>TP</given-names></name><name><surname>Ehricht</surname><given-names>R</given-names></name><name><surname>O&#x02019;Brien</surname><given-names>FG</given-names></name><name><surname>Christiansen</surname><given-names>KJ</given-names></name><article-title>The molecular epidemiology of the highly virulent ST93 Australian community <italic>Staphylococcus aureus</italic> strain</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><issue>8</issue><fpage>e43037</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0043037</pub-id><?supplied-pmid 22900085?><pub-id pub-id-type="pmid">22900085</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Somerville</surname><given-names>GA</given-names></name><name><surname>Cockayne</surname><given-names>A</given-names></name><name><surname>Durr</surname><given-names>M</given-names></name><name><surname>Peschel</surname><given-names>A</given-names></name><name><surname>Otto</surname><given-names>M</given-names></name><name><surname>Musser</surname><given-names>JM</given-names></name><article-title>Synthesis and deformylation of <italic>Staphylococcus aureus</italic> delta-toxin are linked to tricarboxylic acid cycle activity</article-title><source>J Bacteriol</source><year>2003</year><volume>185</volume><issue>22</issue><fpage>6686</fpage><lpage>6694</lpage><pub-id pub-id-type="doi">10.1128/JB.185.22.6686-6694.2003</pub-id><?supplied-pmid 14594843?><pub-id pub-id-type="pmid">14594843</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Diep</surname><given-names>BA</given-names></name><name><surname>Gill</surname><given-names>SR</given-names></name><name><surname>Chang</surname><given-names>RF</given-names></name><name><surname>Phan</surname><given-names>TH</given-names></name><name><surname>Chen</surname><given-names>JH</given-names></name><name><surname>Davidson</surname><given-names>MG</given-names></name><name><surname>Lin</surname><given-names>F</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Carleton</surname><given-names>HA</given-names></name><name><surname>Mongodin</surname><given-names>EF</given-names></name><etal/><article-title>Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant <italic>Staphylococcus aureus</italic></article-title><source>Lancet</source><year>2006</year><volume>367</volume><issue>9512</issue><fpage>731</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(06)68231-7</pub-id><?supplied-pmid 16517273?><pub-id pub-id-type="pmid">16517273</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Howden</surname><given-names>BP</given-names></name><name><surname>Stinear</surname><given-names>TP</given-names></name><name><surname>Allen</surname><given-names>DL</given-names></name><name><surname>Johnson</surname><given-names>PD</given-names></name><name><surname>Ward</surname><given-names>PB</given-names></name><name><surname>Davies</surname><given-names>JK</given-names></name><article-title>Genomic analysis reveals a point mutation in the two-component sensor gene <italic>graS</italic> that leads to intermediate vancomycin resistance in clinical <italic>Staphylococcus aureus</italic></article-title><source>Antimicrob Agents Chemother</source><year>2008</year><volume>52</volume><issue>10</issue><fpage>3755</fpage><lpage>3762</lpage><pub-id pub-id-type="doi">10.1128/AAC.01613-07</pub-id><?supplied-pmid 18644967?><pub-id pub-id-type="pmid">18644967</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Voyich</surname><given-names>JM</given-names></name><name><surname>Otto</surname><given-names>M</given-names></name><name><surname>Mathema</surname><given-names>B</given-names></name><name><surname>Braughton</surname><given-names>KR</given-names></name><name><surname>Whitney</surname><given-names>AR</given-names></name><name><surname>Welty</surname><given-names>D</given-names></name><name><surname>Long</surname><given-names>RD</given-names></name><name><surname>Dorward</surname><given-names>DW</given-names></name><name><surname>Gardner</surname><given-names>DJ</given-names></name><name><surname>Lina</surname><given-names>G</given-names></name><etal/><article-title>Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant <italic>Staphylococcus aureus</italic> disease?</article-title><source>J Infect Dis</source><year>2006</year><volume>194</volume><issue>12</issue><fpage>1761</fpage><lpage>1770</lpage><pub-id pub-id-type="doi">10.1086/509506</pub-id><?supplied-pmid 17109350?><pub-id pub-id-type="pmid">17109350</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Bubeck Wardenburg</surname><given-names>J</given-names></name><name><surname>Palazzolo-Ballance</surname><given-names>AM</given-names></name><name><surname>Otto</surname><given-names>M</given-names></name><name><surname>Schneewind</surname><given-names>O</given-names></name><name><surname>DeLeo</surname><given-names>FR</given-names></name><article-title>Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant <italic>Staphylococcus aureus</italic> disease</article-title><source>J Infect Dis</source><year>2008</year><volume>198</volume><issue>8</issue><fpage>1166</fpage><lpage>1170</lpage><pub-id pub-id-type="doi">10.1086/592053</pub-id><?supplied-pmid 18729780?><pub-id pub-id-type="pmid">18729780</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Chua</surname><given-names>K</given-names></name><name><surname>Seemann</surname><given-names>T</given-names></name><name><surname>Harrison</surname><given-names>PF</given-names></name><name><surname>Davies</surname><given-names>JK</given-names></name><name><surname>Coutts</surname><given-names>SJ</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Haring</surname><given-names>V</given-names></name><name><surname>Moore</surname><given-names>R</given-names></name><name><surname>Howden</surname><given-names>BP</given-names></name><name><surname>Stinear</surname><given-names>TP</given-names></name><article-title>Complete genome sequence of <italic>Staphylococcus aureus</italic> strain JKD6159, a unique Australian clone of ST93-IV community methicillin-resistant <italic>Staphylococcus aureus</italic></article-title><source>J Bacteriol</source><year>2010</year><volume>192</volume><issue>20</issue><fpage>5556</fpage><lpage>5557</lpage><pub-id pub-id-type="doi">10.1128/JB.00878-10</pub-id><?supplied-pmid 20729356?><pub-id pub-id-type="pmid">20729356</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Cue</surname><given-names>D</given-names></name><name><surname>Lei</surname><given-names>MG</given-names></name><name><surname>Luong</surname><given-names>TT</given-names></name><name><surname>Kuechenmeister</surname><given-names>L</given-names></name><name><surname>Dunman</surname><given-names>PM</given-names></name><name><surname>O&#x02019;Donnell</surname><given-names>S</given-names></name><name><surname>Rowe</surname><given-names>S</given-names></name><name><surname>O&#x02019;Gara</surname><given-names>JP</given-names></name><name><surname>Lee</surname><given-names>CY</given-names></name><article-title>Rbf promotes biofilm formation by <italic>Staphylococcus aureus</italic> via repression of <italic>icaR</italic>, a negative regulator of <italic>icaADBC</italic></article-title><source>J Bacteriol</source><year>2009</year><volume>191</volume><issue>20</issue><fpage>6363</fpage><lpage>6373</lpage><pub-id pub-id-type="doi">10.1128/JB.00913-09</pub-id><?supplied-pmid 19684134?><pub-id pub-id-type="pmid">19684134</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Lei</surname><given-names>MG</given-names></name><name><surname>Cue</surname><given-names>D</given-names></name><name><surname>Roux</surname><given-names>CM</given-names></name><name><surname>Dunman</surname><given-names>PM</given-names></name><name><surname>Lee</surname><given-names>CY</given-names></name><article-title>Rsp inhibits attachment and biofilm formation by repressing <italic>fnbA</italic> in <italic>Staphylococcus aureus</italic> MW2</article-title><source>J Bacteriol</source><year>2011</year><volume>193</volume><issue>19</issue><fpage>5231</fpage><lpage>5241</lpage><pub-id pub-id-type="doi">10.1128/JB.05454-11</pub-id><?supplied-pmid 21804010?><pub-id pub-id-type="pmid">21804010</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Montgomery</surname><given-names>CP</given-names></name><name><surname>Boyle-Vavra</surname><given-names>S</given-names></name><name><surname>Daum</surname><given-names>RS</given-names></name><article-title>Importance of the global regulators <italic>agr</italic> and <italic>saeRS</italic> in the pathogenesis of CA-MRSA USA300 infection</article-title><source>PLoS One</source><year>2010</year><volume>5</volume><issue>12</issue><fpage>e15177</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0015177</pub-id><?supplied-pmid 21151999?><pub-id pub-id-type="pmid">21151999</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Cheung</surname><given-names>GY</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Khan</surname><given-names>BA</given-names></name><name><surname>Sturdevant</surname><given-names>DE</given-names></name><name><surname>Otto</surname><given-names>M</given-names></name><article-title>Role of the accessory gene regulator <italic>agr i</italic>n community-associated methicillin-resistant <italic>Staphylococcus aureus</italic> pathogenesis</article-title><source>Infect Immun</source><year>2011</year><volume>79</volume><issue>5</issue><fpage>1927</fpage><lpage>1935</lpage><pub-id pub-id-type="doi">10.1128/IAI.00046-11</pub-id><?supplied-pmid 21402769?><pub-id pub-id-type="pmid">21402769</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Cheung</surname><given-names>AL</given-names></name><name><surname>Eberhardt</surname><given-names>KJ</given-names></name><name><surname>Chung</surname><given-names>E</given-names></name><name><surname>Yeaman</surname><given-names>MR</given-names></name><name><surname>Sullam</surname><given-names>PM</given-names></name><name><surname>Ramos</surname><given-names>M</given-names></name><name><surname>Bayer</surname><given-names>AS</given-names></name><article-title>Diminished virulence of a <italic>sar-/agr-</italic> mutant of <italic>Staphylococcus aureus</italic> in the rabbit model of endocarditis</article-title><source>J Clin Invest</source><year>1994</year><volume>94</volume><issue>5</issue><fpage>1815</fpage><lpage>1822</lpage><pub-id pub-id-type="doi">10.1172/JCI117530</pub-id><?supplied-pmid 7962526?><pub-id pub-id-type="pmid">7962526</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Wright</surname><given-names>JS</given-names><suffix>3rd</suffix></name><name><surname>Jin</surname><given-names>R</given-names></name><name><surname>Novick</surname><given-names>RP</given-names></name><article-title>Transient interference with staphylococcal quorum sensing blocks abscess formation</article-title><source>Proc Natl Acad Sci U S A</source><year>2005</year><volume>102</volume><issue>5</issue><fpage>1691</fpage><lpage>1696</lpage><pub-id pub-id-type="doi">10.1073/pnas.0407661102</pub-id><?supplied-pmid 15665088?><pub-id pub-id-type="pmid">15665088</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Kanehisa</surname><given-names>M</given-names></name><name><surname>Goto</surname><given-names>S</given-names></name><name><surname>Sato</surname><given-names>Y</given-names></name><name><surname>Furumichi</surname><given-names>M</given-names></name><name><surname>Tanabe</surname><given-names>M</given-names></name><article-title>KEGG for integration and interpretation of large-scale molecular data sets</article-title><source>Nucleic Acids Res</source><year>2012</year><volume>40</volume><issue>Database issue</issue><fpage>D109</fpage><lpage>D114</lpage><?supplied-pmid 22080510?><pub-id pub-id-type="pmid">22080510</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Lim</surname><given-names>Y</given-names></name><name><surname>Jana</surname><given-names>M</given-names></name><name><surname>Luong</surname><given-names>TT</given-names></name><name><surname>Lee</surname><given-names>CY</given-names></name><article-title>Control of glucose- and NaCl-induced biofilm formation by <italic>rbf</italic> in <italic>Staphylococcus aureus</italic></article-title><source>J Bacteriol</source><year>2004</year><volume>186</volume><issue>3</issue><fpage>722</fpage><lpage>729</lpage><pub-id pub-id-type="doi">10.1128/JB.186.3.722-729.2004</pub-id><?supplied-pmid 14729698?><pub-id pub-id-type="pmid">14729698</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="book"><name><surname>Rasband</surname><given-names>WS</given-names></name><source>ImageJ</source><publisher-name>Bethesda, Maryland, USA: U S National Institutes of Health</publisher-name><comment>available at
<ext-link ext-link-type="uri" xlink:href="http:/imagej.nih.gov/ij/">http:/imagej.nih.gov/ij/</ext-link>, accessed 9 December 2009 1997&#x02013;2011</comment></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><name><surname>Nguyen</surname><given-names>HM</given-names></name><name><surname>Rocha</surname><given-names>MA</given-names></name><name><surname>Chintalacharuvu</surname><given-names>KR</given-names></name><name><surname>Beenhouwer</surname><given-names>DO</given-names></name><article-title>Detection and quantification of Panton-Valentine leukocidin in <italic>Staphylococcus aureus</italic> cultures by ELISA and Western blotting: diethylpyrocarbonate inhibits binding of protein A to IgG</article-title><source>J Immunol Methods</source><year>2010</year><volume>356</volume><issue>1&#x02013;2</issue><fpage>1</fpage><lpage>5</lpage><?supplied-pmid 20303971?><pub-id pub-id-type="pmid">20303971</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>Bae</surname><given-names>T</given-names></name><name><surname>Schneewind</surname><given-names>O</given-names></name><article-title>Allelic replacement in <italic>Staphylococcus aureus</italic> with inducible counter-selection</article-title><source>Plasmid</source><year>2006</year><volume>55</volume><issue>1</issue><fpage>58</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.plasmid.2005.05.005</pub-id><?supplied-pmid 16051359?><pub-id pub-id-type="pmid">16051359</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name><surname>Monk</surname><given-names>IR</given-names></name><name><surname>Shah</surname><given-names>IM</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Tan</surname><given-names>MW</given-names></name><name><surname>Foster</surname><given-names>TJ</given-names></name><article-title>Transforming the untransformable: application of direct transformation to manipulate genetically <italic>Staphylococcus aureus</italic> and <italic>Staphylococcus epidermidis</italic></article-title><source>MBio</source><year>2012</year><volume>3</volume><issue>2</issue><fpage>e00277</fpage><lpage>00211</lpage><?supplied-pmid 22434850?><pub-id pub-id-type="pmid">22434850</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>MZ</given-names></name><name><surname>Elledge</surname><given-names>SJ</given-names></name><article-title>Harnessing homologous recombination in vitro to generate recombinant DNA via SLIC</article-title><source>Nat Methods</source><year>2007</year><volume>4</volume><issue>3</issue><fpage>251</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1038/nmeth1010</pub-id><?supplied-pmid 17293868?><pub-id pub-id-type="pmid">17293868</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><name><surname>Howden</surname><given-names>BP</given-names></name><name><surname>McEvoy</surname><given-names>CR</given-names></name><name><surname>Allen</surname><given-names>DL</given-names></name><name><surname>Chua</surname><given-names>K</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Harrison</surname><given-names>PF</given-names></name><name><surname>Bell</surname><given-names>J</given-names></name><name><surname>Coombs</surname><given-names>G</given-names></name><name><surname>Bennett-Wood</surname><given-names>V</given-names></name><name><surname>Porter</surname><given-names>JL</given-names></name><etal/><article-title>Evolution of multidrug resistance during <italic>Staphylococcus aureus</italic> infection involves mutation of the essential two component regulator WalKR</article-title><source>PLoS Pathog</source><year>2011</year><volume>7</volume><issue>11</issue><fpage>e1002359</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1002359</pub-id><?supplied-pmid 22102812?><pub-id pub-id-type="pmid">22102812</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><name><surname>Rumble</surname><given-names>SM</given-names></name><name><surname>Lacroute</surname><given-names>P</given-names></name><name><surname>Dalca</surname><given-names>AV</given-names></name><name><surname>Fiume</surname><given-names>M</given-names></name><name><surname>Sidow</surname><given-names>A</given-names></name><name><surname>Brudno</surname><given-names>M</given-names></name><article-title>SHRiMP: accurate mapping of short color-space reads</article-title><source>PLoS Comput Biol</source><year>2009</year><volume>5</volume><issue>5</issue><fpage>e1000386</fpage><pub-id pub-id-type="doi">10.1371/journal.pcbi.1000386</pub-id><?supplied-pmid 19461883?><pub-id pub-id-type="pmid">19461883</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><name><surname>David</surname><given-names>M</given-names></name><name><surname>Dzamba</surname><given-names>M</given-names></name><name><surname>Lister</surname><given-names>D</given-names></name><name><surname>Ilie</surname><given-names>L</given-names></name><name><surname>Brudno</surname><given-names>M</given-names></name><article-title>SHRiMP2: sensitive yet practical SHort Read Mapping</article-title><source>Bioinformatics</source><year>2011</year><volume>27</volume><issue>7</issue><fpage>1011</fpage><lpage>1012</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btr046</pub-id><?supplied-pmid 21278192?><pub-id pub-id-type="pmid">21278192</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><name><surname>Robinson</surname><given-names>MD</given-names></name><name><surname>McCarthy</surname><given-names>DJ</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name><article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title><source>Bioinformatics</source><year>2010</year><volume>26</volume><issue>1</issue><fpage>139</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id><?supplied-pmid 19910308?><pub-id pub-id-type="pmid">19910308</pub-id></mixed-citation></ref></ref-list></back></article>